[1]
2026. METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): DIAGNOSTIC CRITERIA AND EMERGING PHARMACOTHERAPY . "XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TAʼLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR" nomli respublika ilmiy-amaliy konferensiyasi. 4, 9 (Sep. 2026), 129–31.